R
Recursion
Decoding Biology to Radically Improve Lives
Salt Lake City, UT
900+
About Recursion
Industry:
TechBio
Founded:
2013
Founders:
Chris Gibson, Blake Borgeson, Dean Li
Status:
Public (NASDAQ: RXRX)
Funding & Growth
Total Raised:
$1B+
Valuation:
$2B+ market cap
Stage:
Public
Key Investors:
Baillie Gifford
NVIDIA
Bayer
✓ Pros
- • Innovative AI-first approach
- • Unique phenomics platform
- • Strong ML/AI culture
- • Remote-friendly
- • NVIDIA partnership
✗ Cons
- • Salt Lake City location
- • Stock volatility
- • Early drug pipeline
- • Lower base pay (equity heavy)